Kiora Pharmaceuticals to Present Additional Data from Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting : vimarsana.com

Kiora Pharmaceuticals, Inc. , announced that additional data from the ABACUS-1 trial has been accepted for presentation at the Association for Research in Vision and Ophthalmology meeting in...

Related Keywords

United States , Adelaide , South Australia , Australia , Kiora , New South Wales , American , Robert James Casson , Linkedin , Twitter , American Academy Of Ophthalmology , Science At Adelaide University , Kiora Pharmaceuticals , California Newsfile Corp , Kiora Pharmaceuticals Inc , Nasdaq , Association For Research , Professor Robert James Casson , Visual Science , American Academy , Open Innovation , Private Securities Litigation Reform Act , Annual Report , Markets ,